RecruitingNot Applicable

Assessment of Anterior Cruciate Ligament (ACL) Degeneratio Mucosa Treatment

Poland10 participantsStarted 2022-07-01

Plain-language summary

Anterior Cruciate Ligament (ACL) Degeneratio Mucosa is a condition resulting from mucoid degeneration of ACL. Exact etiology is unknown, however ACL Degeneratio Mucosa impairs everyday functioning. In the literature there were some reports of treatment by ACL excision and subsequent reconstruction, however such treatment brings risk of deteriorated function. In this study the investigator will evaluate the technique of ACL "decompression" by the means of longitudinal incisions and evacuation of extrafibrous mucoid tissue.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with ACL degeneratio mucosa decided to undergo a surgical treatment * range of motion impairment caused by mucoid or cystic changes in ACL confirmed by MRI Exclusion Criteria: * non-adherence to the study protocol * active knee inflammation * range of motion impairment due to other extra- and intra-articular reasons

What they're measuring

Range of motion

Timeframe: At the 12 month of the follow-up

Range of motion

Timeframe: At the 24 month of the follow-up

Knee anterior translatory stability

Timeframe: At the 12 month of the follow-up

Knee anterior translatory stability

Timeframe: At the 24 month of the follow-up

Knee anterolateral rotational stability

Timeframe: At the 24 month of the follow-up

Trial details

NCT IDNCT05701579

SponsorArtromedical Konrad Malinowski Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12-31

Contact for this trial

Konrad Malinowski, MD PhD

+48 509812212 malwin8@wp.pl

View on ClinicalTrials.gov More Anterior Cruciate Ligament Injuries trials